Barclays
ELOS

Barclays’s Syneron Medical Ltd ELOS Stock Holding History

Barclays’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,900
Closed -$108K – 7298
2017
Q2 		$108K Buy
9,900
+9,075
+1,100% +$99.5K ﹤0.01% 4843
2017
Q1 		$9K Sell
825
-854
-51% -$8.26K ﹤0.01% 6128
2016
Q4 		$14K Sell
1,679
-833
-33% -$6.53K ﹤0.01% 5795
2016
Q3 		$18K Buy
2,512
+2,500
+20,833% +$17.4K ﹤0.01% 5547
2016
Q2 		$0 Hold
12
– – ﹤0.01% 6875
2016
Q1 		$0 Sell
12
-1
-8% -$7 ﹤0.01% 6678
2015
Q4 		$0 Buy
13
+1
+8% +$8 ﹤0.01% 7021
2015
Q3 		$0 Hold
12
– – ﹤0.01% 7244
2015
Q2 		$0 Sell
12
-1
-8% -$12 ﹤0.01% 7353
2015
Q1 		$0 Buy
+13
New +$144 ﹤0.01% 7385
2014
Q4 		– Sell
-12
Closed – – 7810
2014
Q3 		$0 Sell
12
-100
-89% -$1.02K ﹤0.01% 7955
2014
Q2 		$1K Buy
112
+101
+918% +$1.09K ﹤0.01% 7549
2014
Q1 		$0 Sell
11
-1
-8% -$12 ﹤0.01% 7832
2013
Q4 		$0 Buy
+12
New +$125 ﹤0.01% 7814
2013
Q3 		– Sell
-12
Closed – – 7761
2013
Q2 		$0 Buy
+12
New +$107 ﹤0.01% 7681

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Barclays's ELOS Position: Q3 2017 in Review

Barclays sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 9,900 shares — an estimated $108K sold.

Barclays first reported a position in ELOS in Q2 2013 and held it in 15 quarters. The position peaked at $108K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Barclays reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Barclays sold 9,900 Syneron Medical Ltd shares in Q3 2017, an estimated $108K.
  • Barclays first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 15 quarters.
  • Barclays's Syneron Medical Ltd position peaked at $108K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.